[1] Tormey C A, Hendrickson J E.Transfusion-related red blood cell alloantibodies: induction and consequences[J]. Blood,2019,133(17):1821-1830. [2] Stack G, Tormey C A.Detection rate of blood group alloimmunization based on real-world testing practices and kinetics of antibody induction and evanescence[J]. Transfusion,2016,56(11):2662-2667. [3] Choo S Y.The HLA system: genetics, immunology, clinical testing, and clinical implications[J]. Yonsei Med J,2007,48(1):11-23. [4] Wong K, Lai W K, Jackson D E.HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta-analysis)[J]. Vox Sang, 2022, 117(11):1251-1261. [5] Noizat-Pirenne F, Tournamille C, Bierling P, et al.Relative immunogenicity of Fya and K antigens in a Caucasian population, based on HLA class Ⅱ restriction analysis[J]. Transfusion,2006,46(8):1328-1333. [6] Picard C, Frassati C, Basire A, et al.Positive association of DRB1*04 and DRB1*15 alleles with Fya immunization in a Southern European population[J]. Transfusion,2009,49(11):2412-2417. [7] Reviron D, Dettori I, Ferrera V, et al.HLA-DRB1 alleles and Jka immunization[J]. Transfusion,2005,45(6):956-959. [8] Tian L, Hou L, Wang L X, et al.HLA-DRB1*09:01 allele is associated with anti-E immunization in a Chinese population[J]. Transfusion,2018,58(6):1536-1539. [9] Kong Y J, Xiao J, Tian L, et al.The influence of HLA allele and haplotype on RhE alloimmunization among pregnant females in the Chinese Han population[J]. Vox Sang,2024,119(7):737-744. [10] Shang W L, Ou G J, Ji X, et al.Investigating the correlation between HLA-Ⅱ gene polymorphism and RhE alloimmunization in pregnant Chinese women[J]. Indian J Hematol Blood Transfus,2023,39(4):662-669. [11] Milosavić M, Lilić M, Andrić Z.Impact of human leucocyte antigen class II polymorphism on anti-red blood cell antibody development: Correlations and indications[J]. Vox Sang,2024,119(7):720-727. [12] Schonewille H, Doxiadis I I, Levering W H, et al.HLA-DRB1 associations in individuals with single and multiple clinically relevant red blood cell antibodies[J]. Transfusion,2014,54(8):1971-1980. [13] Maluskova A, Mrazek F, Pauliskova M, et al.Association of HLA-DRB1 and HLA-DQB1 with red-blood-cell alloimmunization in the Czech population[J]. Vox Sang,2017,112(2):156-162. [14] Verduin E P, Brand A, van de Watering L M, et al. The HLA-DRB1*15 phenotype is associated with multiple red blood cell and HLA antibody responsiveness[J]. Transfusion,2016,56(7):1849-1856. [15] 王博,林奇翰,杨龙,等. HLA基因扩增引物、试剂盒、测序文库构建方法及测序方法:CN202111204073.9[P].2024-05-14. [16] de Souza C P, Baleotti W, Moritz E, et al. HLA-DRB1 molecules and the presentation of anchor peptides from RhD, RhCE, and KEL proteins[J]. Transfusion, 2021,61(5):1617-1630. [17] Baleotti W Jr, Ruiz M O, Fabron A Jr, et al.HLA-DRB1*07:01 allele is primarily associated with the Diego a alloimmunization in a Brazilian population[J]. Transfusion,2014,54(10):2468-2476. [18] Gunasekera D, Zimring J C, Pratt K P.A unique major histocompatibility complex Class II-binding register correlates with HLA-DR11-associated immunogenicity of the major K blood group antigen[J]. Transfusion,2018, 58(5):1171-1181. [19] Shao L N, Zhang S T, Yu W J, et al.High-resolution HLA-A, -B and-DRB1 allele and haplotype frequencies in 7823 Han marrow donors of Liaoning Province, China[J]. HLA,2017,89(5):293-300. |